vs

Side-by-side financial comparison of BLACKLINE, INC. (BL) and OPKO HEALTH, INC. (OPK). Click either name above to swap in a different company.

BLACKLINE, INC. is the larger business by last-quarter revenue ($183.2M vs $148.5M, roughly 1.2× OPKO HEALTH, INC.). BLACKLINE, INC. runs the higher net margin — 2.7% vs -21.1%, a 23.7% gap on every dollar of revenue. On growth, BLACKLINE, INC. posted the faster year-over-year revenue change (8.1% vs -19.2%). BLACKLINE, INC. produced more free cash flow last quarter ($26.1M vs $-28.6M). Over the past eight quarters, BLACKLINE, INC.'s revenue compounded faster (7.9% CAGR vs -7.5%).

BlackLine Systems, Inc., is an American enterprise software company that develops cloud-based services designed to automate and manage the entire financial close process as well as consolidation, invoice-to-cash, and intercompany accounting. The Los Angeles–based company has 17 offices worldwide.

OPKO Health, Inc. is a medical test and medication company focused on diagnostics and pharmaceuticals. The company is a publicly traded company on NASDAQ and TASE under the symbol "OPK".

BL vs OPK — Head-to-Head

Bigger by revenue
BL
BL
1.2× larger
BL
$183.2M
$148.5M
OPK
Growing faster (revenue YoY)
BL
BL
+27.3% gap
BL
8.1%
-19.2%
OPK
Higher net margin
BL
BL
23.7% more per $
BL
2.7%
-21.1%
OPK
More free cash flow
BL
BL
$54.6M more FCF
BL
$26.1M
$-28.6M
OPK
Faster 2-yr revenue CAGR
BL
BL
Annualised
BL
7.9%
-7.5%
OPK

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
BL
BL
OPK
OPK
Revenue
$183.2M
$148.5M
Net Profit
$4.9M
$-31.3M
Gross Margin
75.2%
43.1%
Operating Margin
3.7%
-25.8%
Net Margin
2.7%
-21.1%
Revenue YoY
8.1%
-19.2%
Net Profit YoY
-91.3%
-322.8%
EPS (diluted)
$0.07
$-0.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BL
BL
OPK
OPK
Q4 25
$183.2M
$148.5M
Q3 25
$178.3M
$151.7M
Q2 25
$172.0M
$156.8M
Q1 25
$166.9M
$150.0M
Q4 24
$169.5M
$183.6M
Q3 24
$165.9M
$173.6M
Q2 24
$160.5M
$182.2M
Q1 24
$157.5M
$173.7M
Net Profit
BL
BL
OPK
OPK
Q4 25
$4.9M
$-31.3M
Q3 25
$5.3M
$21.6M
Q2 25
$8.3M
$-148.4M
Q1 25
$6.1M
$-67.6M
Q4 24
$56.4M
$14.0M
Q3 24
$17.2M
$24.9M
Q2 24
$76.7M
$-10.3M
Q1 24
$10.8M
$-81.8M
Gross Margin
BL
BL
OPK
OPK
Q4 25
75.2%
43.1%
Q3 25
75.1%
32.9%
Q2 25
75.2%
31.5%
Q1 25
75.5%
28.4%
Q4 24
75.6%
46.1%
Q3 24
75.2%
23.1%
Q2 24
74.9%
28.4%
Q1 24
75.2%
24.2%
Operating Margin
BL
BL
OPK
OPK
Q4 25
3.7%
-25.8%
Q3 25
4.3%
31.7%
Q2 25
4.4%
-38.3%
Q1 25
2.1%
-44.8%
Q4 24
3.7%
-18.0%
Q3 24
5.0%
8.2%
Q2 24
1.4%
-33.9%
Q1 24
1.1%
-41.2%
Net Margin
BL
BL
OPK
OPK
Q4 25
2.7%
-21.1%
Q3 25
3.0%
14.3%
Q2 25
4.8%
-94.7%
Q1 25
3.6%
-45.1%
Q4 24
33.3%
7.6%
Q3 24
10.4%
14.3%
Q2 24
47.8%
-5.7%
Q1 24
6.9%
-47.1%
EPS (diluted)
BL
BL
OPK
OPK
Q4 25
$0.07
$-0.04
Q3 25
$0.09
$0.03
Q2 25
$0.13
$-0.19
Q1 25
$0.10
$-0.10
Q4 24
$0.79
$0.02
Q3 24
$0.27
$0.03
Q2 24
$0.22
$-0.01
Q1 24
$0.17
$-0.12

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BL
BL
OPK
OPK
Cash + ST InvestmentsLiquidity on hand
$390.0M
$364.4M
Total DebtLower is stronger
$344.0M
Stockholders' EquityBook value
$332.3M
$1.3B
Total Assets
$1.8B
$1.9B
Debt / EquityLower = less leverage
0.27×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BL
BL
OPK
OPK
Q4 25
$390.0M
$364.4M
Q3 25
$419.9M
$412.0M
Q2 25
$459.1M
$267.3M
Q1 25
$479.5M
$428.8M
Q4 24
$885.9M
$426.6M
Q3 24
$725.3M
$400.1M
Q2 24
$616.6M
$40.6M
Q1 24
$331.4M
$75.6M
Total Debt
BL
BL
OPK
OPK
Q4 25
$344.0M
Q3 25
$344.2M
Q2 25
$343.3M
Q1 25
$439.2M
Q4 24
$437.2M
Q3 24
$441.0M
Q2 24
$201.9M
Q1 24
$350.1M
Stockholders' Equity
BL
BL
OPK
OPK
Q4 25
$332.3M
$1.3B
Q3 25
$328.3M
$1.3B
Q2 25
$414.0M
$1.3B
Q1 25
$417.9M
$1.3B
Q4 24
$446.7M
$1.4B
Q3 24
$367.9M
$1.4B
Q2 24
$325.8M
$1.4B
Q1 24
$279.8M
$1.3B
Total Assets
BL
BL
OPK
OPK
Q4 25
$1.8B
$1.9B
Q3 25
$1.7B
$2.0B
Q2 25
$1.8B
$2.0B
Q1 25
$1.8B
$2.1B
Q4 24
$1.8B
$2.2B
Q3 24
$1.7B
$2.3B
Q2 24
$1.9B
$2.0B
Q1 24
$2.1B
$2.0B
Debt / Equity
BL
BL
OPK
OPK
Q4 25
0.27×
Q3 25
0.26×
Q2 25
0.26×
Q1 25
0.33×
Q4 24
0.32×
Q3 24
0.31×
Q2 24
0.14×
Q1 24
0.28×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BL
BL
OPK
OPK
Operating Cash FlowLast quarter
$26.7M
$-25.9M
Free Cash FlowOCF − Capex
$26.1M
$-28.6M
FCF MarginFCF / Revenue
14.2%
-19.3%
Capex IntensityCapex / Revenue
0.3%
1.8%
Cash ConversionOCF / Net Profit
5.46×
TTM Free Cash FlowTrailing 4 quarters
$161.5M
$-190.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BL
BL
OPK
OPK
Q4 25
$26.7M
$-25.9M
Q3 25
$63.8M
$-34.6M
Q2 25
$32.3M
$-83.4M
Q1 25
$46.7M
$-34.6M
Q4 24
$43.8M
$-44.4M
Q3 24
$55.9M
$-77.1M
Q2 24
$40.7M
$-26.4M
Q1 24
$50.4M
$-35.6M
Free Cash Flow
BL
BL
OPK
OPK
Q4 25
$26.1M
$-28.6M
Q3 25
$63.3M
$-37.8M
Q2 25
$31.4M
$-86.7M
Q1 25
$40.8M
$-37.7M
Q4 24
$43.0M
$-49.8M
Q3 24
$55.5M
$-85.0M
Q2 24
$40.0M
$-33.7M
Q1 24
$50.1M
$-40.0M
FCF Margin
BL
BL
OPK
OPK
Q4 25
14.2%
-19.3%
Q3 25
35.5%
-24.9%
Q2 25
18.2%
-55.3%
Q1 25
24.4%
-25.2%
Q4 24
25.4%
-27.1%
Q3 24
33.5%
-49.0%
Q2 24
24.9%
-18.5%
Q1 24
31.8%
-23.0%
Capex Intensity
BL
BL
OPK
OPK
Q4 25
0.3%
1.8%
Q3 25
0.3%
2.1%
Q2 25
0.6%
2.1%
Q1 25
3.6%
2.1%
Q4 24
0.4%
2.9%
Q3 24
0.2%
4.6%
Q2 24
0.4%
4.0%
Q1 24
0.2%
2.6%
Cash Conversion
BL
BL
OPK
OPK
Q4 25
5.46×
Q3 25
12.07×
-1.60×
Q2 25
3.90×
Q1 25
7.72×
Q4 24
0.78×
-3.17×
Q3 24
3.24×
-3.10×
Q2 24
0.53×
Q1 24
4.66×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BL
BL

Subscription And Circulation$173.2M95%
Technology Service$10.0M5%

OPK
OPK

Services$71.1M48%
Transfer Of Intellectual Property And Other$33.7M23%
IE$22.1M15%
Rayaldee$8.8M6%
Barda Agreement$6.8M5%
MX$6.3M4%

Related Comparisons